What does CUSIP 87911K100 represent in this 13F holders report?

CUSIP 87911K100 is the security identifier for HQL - abrdn Life Sciences Investors - Common used to aggregate holder disclosures.

How many institutions held HQL - abrdn Life Sciences Investors - Common in Q2 2018?

57 institutional investors reported HQL - abrdn Life Sciences Investors - Common for Q2 2018. Use the holders table for investor-level position and value details.

abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common
Shares outstanding: 29,948,325
Total 13F shares: 3,204,169
Share change: +21,673
Total reported value: $60,229,278
Price per share: $18.79
Number of holders: 57
Value change: +$400,395
Number of buys: 30
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 87911K100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HQL - abrdn Life Sciences Investors - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MORGAN STANLEY	13F	Company	2.2%	652,877	$12,548,000	—	31 Mar 2018	13F
NEEDHAM INVESTMENT MANAGEMENT LLC	13F	Company	1.8%	541,725	$10,412,000	—	31 Mar 2018	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.92%	274,098	$5,268,000	—	31 Mar 2018	13F
FLAGSHIP HARBOR ADVISORS, LLC	13F	Company	0.77%	231,232	$4,260,000	—	31 Mar 2018	13F
Claraphi Advisory Network, LLC	13F	Company	0.68%	202,368	$3,890,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.67%	200,786	$3,859,000	—	31 Mar 2018	13F
COHEN & STEERS, INC.	13F	Company	0.49%	146,796	$2,821,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	0.43%	128,771	$2,475,000	—	31 Mar 2018	13F
LPL Financial LLC	13F	Company	0.23%	68,751	$1,321,000	—	31 Mar 2018	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0.19%	56,834	$1,092,000	—	31 Mar 2018	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	0.19%	55,490	$1,066,000	—	31 Mar 2018	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.17%	52,216	$1,004,000	—	31 Mar 2018	13F
Advisor Group, Inc.	13F	Company	0.17%	51,365	$987,000	—	31 Mar 2018	13F
Advisors Asset Management, Inc.	13F	Company	0.17%	49,562	$955,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.16%	46,645	$896,000	—	31 Mar 2018	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.13%	39,242	$754,000	—	31 Mar 2018	13F
Janney Montgomery Scott LLC	13F	Company	0.13%	37,819	$727,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.13%	37,503	$721,000	—	31 Mar 2018	13F
OPPENHEIMER & CO INC	13F	Company	0.09%	27,760	$534,000	—	31 Mar 2018	13F
STIFEL FINANCIAL CORP	13F	Company	0.09%	27,849	$533,000	—	31 Mar 2018	13F
STEPHENS INC /AR/	13F	Company	0.08%	23,301	$448,000	—	31 Mar 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.07%	22,339	$429,000	—	31 Mar 2018	13F
Private Advisor Group, LLC	13F	Company	0.07%	21,767	$418,000	—	31 Mar 2018	13F
ROYAL BANK OF CANADA	13F	Company	0.07%	20,908	$402,000	—	31 Mar 2018	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.06%	19,017	$365,000	—	31 Mar 2018	13F
DOLIVER ADVISORS, LP	13F	Company	0.05%	14,636	$281,000	—	31 Mar 2018	13F
NORTH STAR ASSET MANAGEMENT INC	13F	Company	0.04%	13,377	$257,000	—	31 Mar 2018	13F
New England Private Wealth Advisors LLC	13F	Company	0.04%	12,494	$240,000	—	31 Mar 2018	13F
IFP Advisors, Inc	13F	Company	0.04%	12,007	$236,000	—	31 Mar 2018	13F
Quad-Cities Investment Group, LLC	13F	Company	0.04%	12,071	$233,000	—	31 Mar 2018	13F
Creative Planning	13F	Company	0.04%	11,450	$220,000	—	31 Mar 2018	13F
UNITED CAPITAL FINANCIAL ADVISORS, LLC	13F	Company	0.04%	10,704	$206,000	—	31 Mar 2018	13F
BB&T SECURITIES, LLC	13F	Company	0.04%	10,695	$205,000	—	31 Mar 2018	13F
Cerity Partners LLC	13F	Company	0.03%	10,000	$192,000	—	31 Mar 2018	13F
Parallel Advisors, LLC	13F	Company	0.02%	7,328	$141,000	—	31 Mar 2018	13F
Ledyard National Bank	13F	Company	0.01%	3,825	$74,000	—	31 Mar 2018	13F
Lee Financial Co	13F	Company	0.01%	3,500	$67,000	—	31 Mar 2018	13F
Steward Partners Investment Advisory, LLC	13F	Company	0.01%	3,299	$63,000	—	31 Mar 2018	13F
VALLEY NATIONAL ADVISERS INC	13F	Company	0.01%	3,029	$58,000	—	31 Mar 2018	13F
Advisory Services Network, LLC	13F	Company	0.01%	2,580	$50,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0.01%	1,934	$37,000	—	31 Mar 2018	13F
Plante Moran Financial Advisors, LLC	13F	Company	0.01%	1,670	$32,000	—	31 Mar 2018	13F
North Star Investment Management Corp.	13F	Company	0%	1,415	$27,000	—	31 Mar 2018	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0%	1,153	$21,000	—	31 Mar 2018	13F
SeaBridge Investment Advisors LLC	13F	Company	0%	956	$18,000	—	31 Mar 2018	13F
RBC Europe Ltd	13F	Company	0%	910	$17,490	—	31 Mar 2018	13F
Stratos Wealth Partners, LTD.	13F	Company	0%	798	$15,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	668	$13,000	—	31 Mar 2018	13F
AdvisorNet Financial, Inc	13F	Company	0%	651	$13,000	—	31 Mar 2018	13F
MARK SHEPTOFF FINANCIAL PLANNING, LLC	13F	Company	0%	465	$9,000	—	31 Mar 2018	13F

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q2 2018

As of 30 Jun 2018, abrdn Life Sciences Investors - Common (HQL) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,204,169 shares. The largest 10 holders included MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, Invesco Ltd., COHEN & STEERS INC, Claraphi Advisory Network, LLC, WOLVERINE ASSET MANAGEMENT LLC, and LPL Financial LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.